Century Therapeutics
-
Century Therapeutics Expands Pipeline with Type 1 Diabetes Drug Candidate
Philadelphia-based Century Therapeutics is broadening its drug development pipeline with a new candidate aimed at treating Type 1 diabetes, an autoimmune disease that affects 2…
-
Philadelphia-based Century Therapeutics Acquires Boston Biotechnology Firm, Clade Therapeutics
Philadelphia-based Century Therapeutics recently raised $60 million in a private placement of almost 16 million shares of its stock and acquired Boston-based Clade Therapeutics, writes…
-
University of Pennsylvania Ranks High for Producing Successful Entrepreneurs Globally
The University of Pennsylvania’s Wharton School of Business’ MBA program and its undergraduate entrepreneurs are responsible for it being among the best entrepreneur-producing institutions worldwide,…
Founding Partners
Advertisement
Affiliate Partners
